{"organizations": [], "uuid": "d3460269146c90aac982981ef292f4f4bbe51449", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wsj.com", "main_image": "https://si.wsj.net/public/resources/images/BN-WY435_ENDO01_SOC_20180111095635.jpg", "site_section": "https://www.wsj.com/europe", "section_title": "The Wall Street Journal &amp; Breaking News, Business, Financial and Economic News, World News and Video", "url": "https://www.wsj.com/articles/government-subpoenas-endo-pharmaceuticals-for-information-on-opioid-products-1515682562", "country": "US", "domain_rank": 387, "title": "Government Subpoenas Endo Pharmaceuticals for Information on Opioid Products", "performance_score": 0, "site": "wsj.com", "participants_count": 1, "title_full": "", "spam_score": 0.656, "site_type": "news", "published": "2018-01-11T17:56:00.000+02:00", "replies_count": 0, "uuid": "d3460269146c90aac982981ef292f4f4bbe51449"}, "author": "Allison Prang", "url": "https://www.wsj.com/articles/government-subpoenas-endo-pharmaceuticals-for-information-on-opioid-products-1515682562", "ord_in_thread": 0, "title": "Government Subpoenas Endo Pharmaceuticals for Information on Opioid Products", "locations": [], "entities": {"persons": [{"name": "ryno eksteen", "sentiment": "none"}, {"name": "endo", "sentiment": "none"}, {"name": "jason bellini", "sentiment": "none"}, {"name": "thomas williams", "sentiment": "none"}], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "government subpoenas endo pharmaceuticals", "sentiment": "negative"}, {"name": "u.s. attorney’s office for the southern district of florida", "sentiment": "neutral"}, {"name": "endo international plc", "sentiment": "none"}, {"name": "endo pharmaceuticals inc.", "sentiment": "none"}, {"name": "wsj", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "The U.S. Attorney’s Office for the Southern District of Florida has issued a grand jury subpoena to Endo Pharmaceuticals Inc. asking for information about opioid-related products, Endo’s parent company announced Thursday.\nThe government is asking for documents about a range of details, including abuse, overdoses, efficacy, addictiveness and withdrawal, Endo International PLC said in a press release.\nEndo... RELATED VIDEO The Way to Save Opioid Addicts | Moving Upstream Addiction experts are in wide agreement on the most effective way to help opioid addicts: Medication-assisted treatment. But most inpatient rehab facilities in the U.S. don’t offer this option. WSJ’s Jason Bellini reports on why the medication option is controversial, and in many places, hard to come by. Image: Ryno Eksteen and Thomas Williams To Read the Full Story Subscribe Sign In", "external_links": [], "published": "2018-01-11T17:56:00.000+02:00", "crawled": "2018-01-12T00:33:48.030+02:00", "highlightTitle": ""}